Bellevue Group’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.67M | Sell |
913,082
-303,674
| -25% | -$2.22M | 0.15% | 76 |
|
|
2025
Q1 | $11.5M | Buy |
1,216,756
+160,960
| +15% | +$1.53M | 0.26% | 69 |
|
|
2024
Q4 | $17.4M | Sell |
1,055,796
-556,816
| -35% | -$9.18M | 0.33% | 70 |
|
|
2024
Q3 | $23.8M | Buy |
1,612,612
+410,516
| +34% | +$6.06M | 0.39% | 67 |
|
|
2024
Q2 | $16.7M | Buy |
1,202,096
+256,071
| +27% | +$3.55M | 0.27% | 82 |
|
|
2024
Q1 | $14.9M | Buy |
+946,025
| New | +$14.9M | 0.23% | 87 |
|
|
2022
Q1 | – | Sell |
-469,695
| Closed | -$16M | – | 194 |
|
|
2021
Q4 | $16M | Sell |
469,695
-91,988
| -16% | -$3.14M | 0.17% | 105 |
|
|
2021
Q3 | $27.1M | Sell |
561,683
-256,630
| -31% | -$12.4M | 0.28% | 95 |
|
|
2021
Q2 | $37M | Buy |
818,313
+30,360
| +4% | +$1.37M | 0.36% | 85 |
|
|
2021
Q1 | $38M | Buy |
787,953
+239,507
| +44% | +$11.6M | 0.4% | 82 |
|
|
2020
Q4 | $29.5M | Buy |
548,446
+121,554
| +28% | +$6.54M | 0.34% | 80 |
|
|
2020
Q3 | $15.7M | Sell |
426,892
-58,578
| -12% | -$2.16M | 0.22% | 97 |
|
|
2020
Q2 | $15M | Buy |
+485,470
| New | +$15M | 0.21% | 90 |
|